189 related articles for article (PubMed ID: 21903145)
1. Highly compacted DNA nanoparticles with low MW PEG coatings: in vitro, ex vivo and in vivo evaluation.
Boylan NJ; Suk JS; Lai SK; Jelinek R; Boyle MP; Cooper MJ; Hanes J
J Control Release; 2012 Jan; 157(1):72-9. PubMed ID: 21903145
[TBL] [Abstract][Full Text] [Related]
2. Non-degradative intracellular trafficking of highly compacted polymeric DNA nanoparticles.
Kim AJ; Boylan NJ; Suk JS; Lai SK; Hanes J
J Control Release; 2012 Feb; 158(1):102-7. PubMed ID: 22079809
[TBL] [Abstract][Full Text] [Related]
3. N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles.
Suk JS; Boylan NJ; Trehan K; Tang BC; Schneider CS; Lin JM; Boyle MP; Zeitlin PL; Lai SK; Cooper MJ; Hanes J
Mol Ther; 2011 Nov; 19(11):1981-9. PubMed ID: 21829177
[TBL] [Abstract][Full Text] [Related]
4. Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier.
Suk JS; Kim AJ; Trehan K; Schneider CS; Cebotaru L; Woodward OM; Boylan NJ; Boyle MP; Lai SK; Guggino WB; Hanes J
J Control Release; 2014 Mar; 178():8-17. PubMed ID: 24440664
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of airway gene transfer by DNA nanoparticles using a pH-responsive block copolymer of polyethylene glycol and poly-L-lysine.
Boylan NJ; Kim AJ; Suk JS; Adstamongkonkul P; Simons BW; Lai SK; Cooper MJ; Hanes J
Biomaterials; 2012 Mar; 33(7):2361-71. PubMed ID: 22182747
[TBL] [Abstract][Full Text] [Related]
6. Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine.
Suk JS; Lai SK; Boylan NJ; Dawson MR; Boyle MP; Hanes J
Nanomedicine (Lond); 2011 Feb; 6(2):365-75. PubMed ID: 21385138
[TBL] [Abstract][Full Text] [Related]
7. Preparation and analysis of PEGylated poly-L-lysine DNA nanoparticles for gene delivery.
Davis PB; Kowalczyk TH
Cold Spring Harb Protoc; 2010 May; 2010(5):pdb.prot5419. PubMed ID: 20439407
[TBL] [Abstract][Full Text] [Related]
8. PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy.
Osman G; Rodriguez J; Chan SY; Chisholm J; Duncan G; Kim N; Tatler AL; Shakesheff KM; Hanes J; Suk JS; Dixon JE
J Control Release; 2018 Sep; 285():35-45. PubMed ID: 30004000
[TBL] [Abstract][Full Text] [Related]
9. String-like micellar nanoparticles formed by complexation of PEG-b-PPA and plasmid DNA and their transfection efficiency.
Jiang X; Leong D; Ren Y; Li Z; Torbenson MS; Mao HQ
Pharm Res; 2011 Jun; 28(6):1317-27. PubMed ID: 21499836
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle penetration of human cervicovaginal mucus: the effect of polyvinyl alcohol.
Yang M; Lai SK; Yu T; Wang YY; Happe C; Zhong W; Zhang M; Anonuevo A; Fridley C; Hung A; Fu J; Hanes J
J Control Release; 2014 Oct; 192():202-8. PubMed ID: 25090196
[TBL] [Abstract][Full Text] [Related]
11. Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo.
Xu Q; Ensign LM; Boylan NJ; Schön A; Gong X; Yang JC; Lamb NW; Cai S; Yu T; Freire E; Hanes J
ACS Nano; 2015 Sep; 9(9):9217-27. PubMed ID: 26301576
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier.
Tang BC; Dawson M; Lai SK; Wang YY; Suk JS; Yang M; Zeitlin P; Boyle MP; Fu J; Hanes J
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19268-73. PubMed ID: 19901335
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles coated with high molecular weight PEG penetrate mucus and provide uniform vaginal and colorectal distribution in vivo.
Maisel K; Reddy M; Xu Q; Chattopadhyay S; Cone R; Ensign LM; Hanes J
Nanomedicine (Lond); 2016 Jun; 11(11):1337-43. PubMed ID: 27171816
[TBL] [Abstract][Full Text] [Related]
14. Polyethylene glycol-conjugated copolymers for plasmid DNA delivery.
Lee M; Kim SW
Pharm Res; 2005 Jan; 22(1):1-10. PubMed ID: 15771224
[TBL] [Abstract][Full Text] [Related]
15. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.
Suk JS; Xu Q; Kim N; Hanes J; Ensign LM
Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):28-51. PubMed ID: 26456916
[TBL] [Abstract][Full Text] [Related]
16. Complex Coacervation-Integrated Hybrid Nanoparticles Increasing Plasmid DNA Delivery Efficiency in Vivo.
Li Y; Humphries B; Wang Z; Lang S; Huang X; Xiao H; Jiang Y; Yang C
ACS Appl Mater Interfaces; 2016 Nov; 8(45):30735-30746. PubMed ID: 27781434
[TBL] [Abstract][Full Text] [Related]
17. PEGylation for enhancing nanoparticle diffusion in mucus.
Huckaby JT; Lai SK
Adv Drug Deliv Rev; 2018 Jan; 124():125-139. PubMed ID: 28882703
[TBL] [Abstract][Full Text] [Related]
18. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus.
Henry CE; Wang YY; Yang Q; Hoang T; Chattopadhyay S; Hoen T; Ensign LM; Nunn KL; Schroeder H; McCallen J; Moench T; Cone R; Roffler SR; Lai SK
Acta Biomater; 2016 Oct; 43():61-70. PubMed ID: 27424083
[TBL] [Abstract][Full Text] [Related]
19. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles.
Suk JS; Lai SK; Wang YY; Ensign LM; Zeitlin PL; Boyle MP; Hanes J
Biomaterials; 2009 May; 30(13):2591-7. PubMed ID: 19176245
[TBL] [Abstract][Full Text] [Related]
20. Efficient topical delivery of plasmid DNA to lung in vivo mediated by putative triggered, PEGylated pDNA nanoparticles.
Aissaoui A; Chami M; Hussein M; Miller AD
J Control Release; 2011 Sep; 154(3):275-84. PubMed ID: 21699935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
